Helping Hospitals Manage Controlled Prescription Drugs (CPDs) through Medication Monitoring and Comprehensive Toxicology Reporting

Hospitals and healthcare systems are being charged with the health and wellness of the community of patients they serve. Over the past decade, hospitals have actively acquired physician practices and have moved towards a population health management model with the goal of reducing costs while improving patient care and outcomes. As a consequence of hospitals building their provider networks through acquisition, they have also assumed risk in the management of CPDs for their patient population. CPDs include opioids, benzodiazepines, amphetamines, stimulants, muscle relaxers, and sleep aids. CPDs can be effectively monitored for misuse, abuse, and diversion with a comprehensive medication monitoring protocol utilizing high sensitivity definitive toxicology testing.

LabSource works closely with hospital clients delivering an effective medication monitoring protocol through Risk Stratification models, pharmacogenetics and the latest in toxicology testing methodology to help hospitals and providers quickly recognize potential misuse, abuse, and diversion of CPDs, as well as testing for illicit drug use. Utilizing a dedicated clinical toxicology laboratory as a part of your medication monitoring protocol will deliver to your providers consistent and comprehensive toxicology reporting. The LabSource Science Leadership team has extensive experience working in the hospital environment and can provide research support, payer support, hospital client bill, in-sourcing toxicology laboratory development, and EMR & LIS interfaces.

Ask about our Hospital Client Bill Program

Successful Hospital Management of CPDs includes:

  • Cost Containment through Better Management of CPD Use in Your Patient Population
  • Better Patient Outcomes with High Sensitivity Definitive Toxicology Testing
  • Pharmacogenetics Testing for Effective CPD Treatment
  • Rapid ROI with our Hospital Client Bill Program
  • Increase Hospital Revenue by Capturing Outsourced Revenue

How can Hospitals Use Pharmacogenetics to Improve Patients' Outcomes?

  • Proactively Address a Patient’s Poor Therapeutic Response to an Opioid, Benzodiazepine, or Antidepressant Treatment
  • Evaluate Genetic Pathways in Patients with a History of Allergic or Adverse Reactions to Medications
  • Evaluate Prescription Treatment Options for Patients with a History of Substance Abuse and Relapse
  • Collect Additional Data Points for Patients with Unusual Toxicology Results (i.e. drug metabolites not present)

The LabSource Difference...

High Sensitivity Definitive Toxicology Testing

STAT Accounts Receive Expedited High Sensitivity Definitive Toxicology Testing Results.

30 Day Account Integration – LabSource Quickly Communicates Issues That Can Affect Testing and Turn-Around Time.

High Sensitivity Enzymatic Specimen Incubation Converts All Drugs and Metabolites to a Free-Detectable Form.

Solid Phase Extraction & Concentrate Eliminates Interferences and Extracts Drugs to Increase Sensitivity. Evaporates Liquid Leaving High Concentrations of Drugs for Maximum Sensitivity.

Proprietary Software Verifies Accuracy of All Detected Drugs with Results Reviewed by Two Certifying Scientists.

Patient Results are Compared to the Patient’s Previous Results.

Multi-Level Verification Process for Positive Non-Prescribed Medications.

Automatic Re-test and Verification of Unexpected Results; We Re-test 10% of Specimens.

contact us

Ask About Our Clinical Toxicology Testing Services

   call now   LabSource Phone   (877) 930-3390